Teva Pharmaceutical Industries Ltd. (TEVA) Gains As Market Dips: What You Should Know

- Advertisement -
- Advertisement -
- Advertisement -
- Advertisement -

Teva Pharmaceutical Industries Ltd. (TEVA) closed at $9.54 in the latest trading session, marking a +0.85% move from the prior day. The stock outpaced the S&P 500’s daily loss of 0.16%. Meanwhile, the Dow lost 0.12%, and the Nasdaq, a tech-heavy index, lost 0.33%.

Coming into today, shares of the company had gained 6.53% in the past month. In that same time, the Medical sector lost 8.16%, while the S&P 500 lost 10.5%.

TEVA will be looking to display strength as it nears its next earnings release. In that report, analysts expect TEVA to post earnings of $0.58 per share. This would mark a year-over-year decline of 3.33%. Meanwhile, our latest consensus estimate is calling for revenue of $4.13 billion, down 3.84% from the prior-year quarter.

Looking at the full year, our Zacks Consensus Estimates suggest analysts are expecting earnings of $2.44 per share and revenue of $16.67 billion. These totals would mark changes of +1.67% and -3.97%, respectively, from last year.

Investors might also notice recent changes to analyst estimates for TEVA. These recent revisions tend to reflect the evolving nature of short-term business trends. With this in mind, we can consider positive estimate revisions a sign of optimism about the company’s business outlook.

Our research shows that these estimate changes are directly correlated with near-term stock prices. Investors can capitalize on this by using the Zacks Rank. This model considers these estimate changes and provides a simple, actionable rating system.

The Zacks Rank system ranges from #1 (Strong Buy) to #5 (Strong Sell). It has a remarkable, outside-audited track record of success, with #1 stocks delivering an average annual return of +25% since 1988. The Zacks Consensus EPS estimate has moved 0.97% lower within the past month. TEVA is holding a Zacks Rank of #3 (Hold) right now.

Looking at its valuation, TEVA is holding a Forward P/E ratio of 3.88. Its industry sports an average Forward P/E of 5.84, so we one might conclude that TEVA is trading at a discount comparatively.

Home of Science
Follow me

- Advertisement -

Discover

Sponsor

Latest

What will Jacob Rees-Mogg do in his new job?on February 10, 2022 at 2:10 am

Parliament's poster boy for Brexit is now the minister tasked with seizing any opportunities it may bring.

The Papers: Tory revolt bruises PM and 1m face festive isolationon December 15, 2021 at 12:04 am

Most papers lead on the Commons rebellion by almost 100 Tory MPs over Covid passes in England.

Ukraine: What are Russia’s possible attack routes?on February 18, 2022 at 4:13 pm

Russia insists it has no plan to invade, but the US says it could strike at any time.

MLB: ‘Beautiful’ – Watch Kansas City Royals’ Nicky Lopez brilliant diving catchon April 8, 2022 at 9:17 am

Watch Kansas City Royals' Nicky Lopez's brilliant diving catch to deny a hit from Cleveland Guardians' Amed Rosario on the opening day of the...

The Papers: ‘Gunned down at bedtime’on August 23, 2022 at 11:51 pm

The shooting of nine-year-old Olivia Pratt-Korbel at her home in Liverpool dominates the front pages.The shooting of nine-year-old Olivia Pratt-Korbel at her home in...
Home of Science
Follow me